US StockDetailed Quotes

Provided by Tiger Fintech (Singapore) Pte. Ltd.

Omeros

6.34

-0.4700-6.90%

Pre-market: 6.560.2197+3.47%08:51 EDT

Volume:801.16K

Turnover:5.18M

Market Cap:368.13M

PE:-2.35

High:7.08

Open:6.72

Low:6.27

Close:6.81

Loading ...

Overview Company News Filings

Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA

Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges

Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting

Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting

Omeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on News

BRIEF-Omeros Provides Update On Progress Toward BLA Resubmission For Narsoplimab

Rpt-Omeros Corp - Independent Expert Statistical Group to Conduct Analyses

THOMSON REUTERS

Rpt-Omeros Corp - Receives FDA Response on Revised Sap for Narsoplimab Bla

THOMSON REUTERS

Rpt-Omeros Corporation Provides Update on Progress Toward Bla Resubmission

THOMSON REUTERS

Corrected-Omeros Corp - FDA Had Previously Requested Additional Sensitivity Analyses for Sap (Adds Dropped Words 'Had Previously Requested')

THOMSON REUTERS

Omeros provides update on narsoplimab BLA resubmission

Omeros Corp - Receives FDA Response on Revised Sap for Narsoplimab Bla

THOMSON REUTERS

Omeros Corporation Provides Update on Progress Toward Bla Resubmission

THOMSON REUTERS

Omeros Corp - FDA Requests Additional Sensitivity Analyses for Sap

THOMSON REUTERS

Omeros Corp - Independent Expert Statistical Group to Conduct Analyses

THOMSON REUTERS

Omeros Corporation Provides Update on Progress Toward BLA Resubmission

OMER S.p.a. Receives Buy Rating: Strong Financial Performance and Strategic Advancements Drive Confidence

OMER Reports Strong Third Quarter Growth

Omeros Shares Hit 52-Week High on Plan to Resubmit Narsoplimab Application

Omeros Initiated at Buy by Rodman & Renshaw

{"basename":"","ssrTDKData":{"titleTemplate":"%s - Tiger Brokers","title":"Tiger Brokers | Global Stocks, Options & Futures Trading App","description":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","keywords":"tiger brokers,tiger trade,tiger brokers singapore,broker online,stock trading in singapore,share trading singapore,brokerage firm singapore,trading app,stock broker singapore,stock trading platforms,trading account","social":{"ogDescription":"Tiger Brokers, one-stop investment in US stocks, SGX stocks, HK stocks, A-shares & other global assets. One of the best stock trading platforms in Singapore.","ogImage":"https://c1.itigergrowtha.com/portal5/static/media/og-logo.be62fbe1.png","ogUrl":"https://www.itiger.com/stock/OMER/news?page=4"},"companyName":"Tiger Brokers"},"pageData":{"isMobile":false,"isTiger":false,"isTTM":true,"region":"SGP","license":"TBSG","edition":"fundamental","symbol":"OMER","isAnalysisPage":false},"__swrFallback__":{"@#url:\"https://hq.skytigris.cn/stock_info/detail/global\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OMER\",,,,,undefined,":{"symbol":"OMER","market":"US","secType":"STK","nameCN":"Omeros","latestPrice":6.34,"timestamp":1746561600000,"preClose":6.81,"halted":0,"volume":801159,"hourTrading":{"tag":"盘前","latestPrice":6.5597,"preClose":6.34,"latestTime":"08:51 EDT","volume":1304,"amount":8451.280463199999,"timestamp":1746622273225},"delay":0,"floatShares":55487959,"shares":58063901,"eps":-2.695762,"marketStatus":"Pre-Mkt","change":-0.47,"latestTime":"05-07 09:26:07 EDT","open":6.72,"high":7.08,"low":6.265,"amount":5182883.1194244,"amplitude":0.119677,"askPrice":8.26,"askSize":300,"bidPrice":6,"bidSize":2000,"shortable":3,"etf":0,"ttmEps":-2.695762,"tradingStatus":1,"nextMarketStatus":{"tag":"Open","tradingStatus":2,"beginTime":1746624600000},"marketStatusCode":1,"adr":0,"adrRate":0,"listingDate":1254974400000,"exchange":"NASDAQ","adjPreClose":6.34,"preHourTrading":{"tag":"盘前","latestPrice":6.5597,"preClose":6.34,"latestTime":"08:51 EDT","volume":1304,"amount":8451.280463199999,"timestamp":1746622273225},"postHourTrading":{"tag":"盘后","latestPrice":6.4501,"preClose":6.34,"latestTime":"19:57 EDT","volume":15650,"amount":99534.968,"timestamp":1746575854313},"volumeRatio":1.926632707262218,"impliedVol":1.0382,"impliedVolPercentile":0.8715},"@#url:\"https://hq.skytigris.cn/stock_info/fundamental/all\",params:#delay:false,,method:\"POST\",data:#items:@#symbol:\"OMER\",,,,,undefined,":{"symbol":"OMER","floatShares":55487959,"roa":"-32.28%","roe":"-576.33%","lyrEps":-2.695762,"volumeRatio":1.926632707262218,"shares":58063901,"dividePrice":0,"high":7.08,"amplitude":0.119677,"preClose":6.81,"low":6.265,"week52Low":3.0001,"pbRate":"-2.02","psRate":"-12.27","week52High":13.6,"institutionHeld":0,"latestPrice":6.34,"committee":0.73913,"eps":-2.695762,"divideRate":0,"volume":801159,"delay":0,"ttmEps":-2.695762,"open":6.72,"prevYearClose":9.88,"fiveDayClose":7.21,"twentyDayClose":6.895,"sixtyDayClose":8.65},"$inf$@#url:\"https://stock-news.skytigris.cn/v2/news/list\",params:#symbols:\"OMER\",pageSize:20,pageCount:4,lang_content:\"en\",edition:\"fundamental\",,,undefined,":[{"items":[{"id":"2492179355","title":"Omeros’ Narsoplimab Meets its Pivotal Trial Primary Endpoint – Statistical Analysis Shows Survival Superiority Over External Control in Patients with TA-TMA","url":"https://stock-news.laohu8.com/highlight/detail?id=2492179355","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2492179355?lang=en_us&edition=fundamental","pubTime":"2024-12-19 22:15","pubTimestamp":1734617700,"startTime":"0","endTime":"0","summary":"Primary statistical analysis of overall survival compared TA-TMA patients treated with narsoplimab in its pivotal trial to a cohort of over 100 TA-TMA patients not treated with narsoplimab in an external control stem cell transplant registry; FDA-agreed analysis was conducted by an independent external statistical group. \"The results of this comparative survival analysis for narsoplimab in TA-TMA are truly outstanding,\" stated Alessandro Rambaldi, M.D., Professor of Hematology at the University of Milan and Head of the Hematology and Bone Marrow Transplant Unit at ASST Papa Giovanni XXIII in Bergamo, Italy. \"As an investigator in the pivotal clinical trial and having since requested and used narsoplimab in a good number of very sick TA-TMA patients through the expanded access program, we have seen first-hand the impressive benefits of narsoplimab in these high-risk patients. While we do not use C5 inhibitors in our transplant patients, nearly 50 patients in the expanded access program ","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/woUQeP7qpLty8qYTbWsKrw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8a2f3eaead10ec9eae764fa1a1ec3651","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/woUQeP7qpLty8qYTbWsKrw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8a2f3eaead10ec9eae764fa1a1ec3651"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-narsoplimab-meets-pivotal-trial-141500583.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4007","SAP","BK4588","OMER","MAA","BK4023","HSCT","BK4528","BK4585","BK4215"],"gpt_icon":0},{"id":"2490414530","title":"Omeros Corp (OMER): Profit-Taking Time Amid ASH Presentations and Financial Challenges","url":"https://stock-news.laohu8.com/highlight/detail?id=2490414530","media":"Insider Monkey","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490414530?lang=en_us&edition=fundamental","pubTime":"2024-12-11 01:22","pubTimestamp":1733851350,"startTime":"0","endTime":"0","summary":"We recently published a list of Jim Cramer’s Lightning Rounds: 12 Stocks Under the Spotlight. In this article, we are going to take a look at where Omeros Corporation  stands against other stocks under Jim Cramer's lightning rounds' spotlight.Jim Cramer, host of Mad Money, recently discussed the outlook for the stock market following a year of strong gains, cautioning that investors’ overly optimistic expectations for Federal Reserve rate cuts could lead to trouble. As the year draws to a close, brokerages are releasing their official market predictions for 2025, and so far, they are almost universally positive.He said that this optimism is understandable given the strong earnings season and the significant stock market rally following the election. Cramer noted that many investors are betting that a business-friendly administration will continue to drive better returns.For this article, we compiled a list of 12 stocks that were discussed by Jim Cramer during recent episodes of Mad Mon","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/PzgWkUedCz5KdZjbTR3fkA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/53298a11f85c876aabe6ac8c5856e2a7","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/PzgWkUedCz5KdZjbTR3fkA--~B/aD04MTY7dz0xNDU2O2FwcGlkPXl0YWNoeW9u/https://media.zenfs.com/en/insidermonkey.com/53298a11f85c876aabe6ac8c5856e2a7"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-corp-omer-profit-taking-172230938.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"-1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["QLD","MNQmain","US6M.BOND","US2Y.BOND","TQQQ","ASH","NQmain","US3Y.BOND","LU2463526074.USD","QID","PSQ","US30Y.BOND","US5Y.BOND","US7Y.BOND","SQQQ","OMER","BK4109",".IXIC","BK4007","US12M.BOND","US10Y.BOND"],"gpt_icon":1},{"id":"2490701532","title":"Omeros Corporation Announces Presentation of Positive Zaltenibart Data at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2490701532","media":"Business Wire","labels":["dataReport"],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2490701532?lang=en_us&edition=fundamental","pubTime":"2024-12-10 21:45","pubTimestamp":1733838300,"startTime":"0","endTime":"0","summary":"-- Clinical Trial and Clinical Pharmacology Data Support Upcoming Enrollment of Omeros’ Zaltenibart Phase 3 Clinical Program in PNH --. SEATTLE, December 10, 2024----Omeros Corporation  today announced that two posters directed to zaltenibart , Omeros’ investigational inhibitor of MASP-3, the key and most proximal activator of the alternative pathway of complement, were presented at the 66th Annual Meeting of the American Society of Hematology  yesterday in San Diego. The posters, both addressing zaltenibart in paroxysmal nocturnal hemoglobinuria  – a rare, life-threatening hematological disorder – detail positive Phase 2 clinical data and clinical pharmacology analyses supporting zaltenibart dose selection for the PNH Phase 3 program. Enrollment for the zaltenibart Phase 3 clinical trials in PNH is expected to open in early 2025.Zaltenibart  is an investigational human monoclonal antibody targeting mannan-binding lectin-associated serine protease-3 , the key and most proximal activato","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/f1eohffvki86vEm7rHdNnw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bdb0af314a40b16a2dd3479ea9b7b5bc","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/f1eohffvki86vEm7rHdNnw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/bdb0af314a40b16a2dd3479ea9b7b5bc"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-corporation-announces-presentation-positive-134500512.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"dataReport","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["BK4109","OMER","LU2463526074.USD","BK4007","ASH"],"gpt_icon":0},{"id":"2488957969","title":"Omeros Corporation Announces Upcoming Presentations at ASH Annual Meeting","url":"https://stock-news.laohu8.com/highlight/detail?id=2488957969","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2488957969?lang=en_us&edition=fundamental","pubTime":"2024-12-02 21:45","pubTimestamp":1733147100,"startTime":"0","endTime":"0","summary":"-- Presentations Highlight Progress in Late-Stage Development of Lead MASP-3 Inhibitor Zaltenibart --. SEATTLE, December 02, 2024----Omeros Corporation  today announced that two abstracts directed to zaltenibart , Omeros’ investigational inhibitor of MASP-3, the key activator of the alternative pathway of complement, will be presented at the 66th Annual Meeting of the American Society of Hematology , to be held December 7-10, 2024 in San Diego. The zaltenibart abstracts are directed to the treatment of paroxysmal nocturnal hemoglobinuria , a rare, life-threatening hematological disorder. Enrollment for the zaltenibart Phase 3 clinical trials in PNH is expected to open in early 2025.","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/X8rOnvPYPdwEug9.Eg0dYw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8ddfa7aea6799bf043d8ad6e529895be","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/X8rOnvPYPdwEug9.Eg0dYw--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/8ddfa7aea6799bf043d8ad6e529895be"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-corporation-announces-upcoming-presentations-134500315.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2463526074.USD","BK4007","BK4109","ASH","OMER"],"gpt_icon":0},{"id":"2485239213","title":"Omeros Updates Progress on Narsoplimab Biologics License Resubmission; Stock up Over 30% on News","url":"https://stock-news.laohu8.com/highlight/detail?id=2485239213","media":"GuruFocus","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485239213?lang=en_us&edition=fundamental","pubTime":"2024-11-23 03:31","pubTimestamp":1732303901,"startTime":"0","endTime":"0","summary":"Omeros  announced progress toward resubmitting its biologics license application for narsoplimab, its antibody targeting MASP-2 for treating hematopoietic stem cell transplant-associated thrombotic microangiopathy; Omeros shares are up 32.3% to $10.23 in Friday's morning trading, following the news.The business acknowledged that it is getting ready the required data for submission and has responded to comments from the U.S. Food and Drug Administration on its updated statistical analysis plan.Omeros said the FDA does not have any more presubmission information requirements, hence the business is not aware of any challenges to finish the resubmission process. An independent statistical group will handle the main endpoint and additional analyses after data preparation is complete. Should the findings support the application, the business intends to swiftly resubmit the BLA.Feedback from the FDA during a September 2024 conference includes further sensitivity studies for the main effective","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.gurufocus.com/news/2613947/omeros-updates-progress-on-narsoplimab-biologics-license-resubmission-stock-up-over-30-on-news","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"2","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"gurufocus_highlight","symbols":["BK4097","PRGS","OMER","LU2065732104.USD","BK4007"],"gpt_icon":0},{"id":"2485497574","title":"BRIEF-Omeros Provides Update On Progress Toward BLA Resubmission For Narsoplimab","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497574","media":"Reuters","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485497574?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:40","pubTimestamp":1732200004,"startTime":"0","endTime":"0","summary":"Nov 21  - Omeros Corp   :   * OMEROS CORPORATION PROVIDES UPDATE ON PROGRESS TOWARD BLA RESUBMISSION   * OMEROS CORP - FDA HAD PREVIOUSLY REQUESTED ADDITIONAL SENSITIVITY ANALYSES FOR SAP    * OMEROS CORP - RECEIVES FDA RESPONSE ON REVISED SAP FOR NARSOPLIMAB BLA   * OMEROS CORP - INDEPENDENT EXPERT STATISTICAL GROUP TO CONDUCT ANALYSESSource text:    Further company coverage:    ","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.rkd.refinitiv.com/api/News/News.svc/REST/News_1/RetrieveStoryML_1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["LU1861219969.SGD","LU2065732104.USD","IE00BD6J9T35.USD","LU1861220033.SGD","LU1861215975.USD","LU2360107325.USD","OMER","BK4585","BK4097","BK4512","LU0724618433.USD","BK4007","ON","BK4141","LU1548497426.USD","LU1720051017.SGD","LU1720051108.HKD","LU1854104046.USD","PRGS","LU1978683503.SGD","LU0348723411.USD","BK4588","LU2357305700.SGD","LU1861214812.USD","IE00BZ199S13.USD","LU0124384867.USD","LU1854103824.USD","LU2298322129.HKD"],"gpt_icon":0},{"id":"2485497551","title":"Rpt-Omeros Corp - Independent Expert Statistical Group to Conduct Analyses","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497551","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485497551?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:40","pubTimestamp":1732200004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL8N3MS1BU:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2485497530","title":"Rpt-Omeros Corp - Receives FDA Response on Revised Sap for Narsoplimab Bla","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497530","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485497530?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:40","pubTimestamp":1732200004,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL8N3MS1BU:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2485497532","title":"Rpt-Omeros Corporation Provides Update on Progress Toward Bla Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2485497532","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485497532?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:40","pubTimestamp":1732200003,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL8N3MS1BU:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2485975524","title":"Corrected-Omeros Corp - FDA Had Previously Requested Additional Sensitivity Analyses for Sap (Adds Dropped Words 'Had Previously Requested')","url":"https://stock-news.laohu8.com/highlight/detail?id=2485975524","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485975524?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:40","pubTimestamp":1732200002,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nL8N3MS1BU:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2485041492","title":"Omeros provides update on narsoplimab BLA resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2485041492","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485041492?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:25","pubTimestamp":1732199133,"startTime":"0","endTime":"0","summary":"Omeros (OMER) announced an update on its progress toward planned resubmission of its biologics license application, or BLA, for narsoplimab, the co...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/the-fly/omeros-provides-update-on-narsoplimab-bla-resubmission?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/the-fly/omeros-provides-update-on-narsoplimab-bla-resubmission?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2485949374","title":"Omeros Corp - Receives FDA Response on Revised Sap for Narsoplimab Bla","url":"https://stock-news.laohu8.com/highlight/detail?id=2485949374","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485949374?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:15","pubTimestamp":1732198500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA3GJ9NW:2","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2485679494","title":"Omeros Corporation Provides Update on Progress Toward Bla Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2485679494","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485679494?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:15","pubTimestamp":1732198500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA3GJ9NW:1","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["BK4007","OMER"],"gpt_icon":0},{"id":"2485494934","title":"Omeros Corp - FDA Requests Additional Sensitivity Analyses for Sap","url":"https://stock-news.laohu8.com/highlight/detail?id=2485494934","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485494934?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:15","pubTimestamp":1732198500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA3GJ9NW:4","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2485494932","title":"Omeros Corp - Independent Expert Statistical Group to Conduct Analyses","url":"https://stock-news.laohu8.com/highlight/detail?id=2485494932","media":"THOMSON REUTERS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485494932?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:15","pubTimestamp":1732198500,"startTime":"0","endTime":"0","summary":null,"market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://api.refinitiv.com/data/news/v1/stories/urn:newsml:reuters.com:20241121:nTUA3GJ9NW:3","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"reuters_en_live","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2485490343","title":"Omeros Corporation Provides Update on Progress Toward BLA Resubmission","url":"https://stock-news.laohu8.com/highlight/detail?id=2485490343","media":"Business Wire","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2485490343?lang=en_us&edition=fundamental","pubTime":"2024-11-21 22:15","pubTimestamp":1732198500,"startTime":"0","endTime":"0","summary":"SEATTLE, November 21, 2024----Omeros Corporation  today announced an update on its progress toward planned resubmission of its biologics license application  for narsoplimab, the company’s first-in-class antibody targeting MASP-2, the effector enzyme of the lectin pathway of complement, in hematopoietic stem cell transplant-associated thrombotic microangiopathy . In last week’s quarterly earnings release and associated call, Omeros stated that it was awaiting feedback from the U.S. Food and Drug Administration  on the company’s revised statistical analysis plan  for the BLA. Omeros has now received FDA’s response on the revised SAP, has no other presubmission information requests pending and is not aware of any other impediment to resubmitting the narsoplimab BLA. Following data preparation, primary endpoint and other analyses will be conducted by an independent expert statistical group. If the analytical results support resubmission of the BLA, the company plans to finalize and resubm","market":"us","thumbnail":"https://s.yimg.com/uu/api/res/1.2/x096ECSowGg3Q1rFZ1g9Dg--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e0473bd79b4b38b19db2bf46f63a9a2e","type":0,"news_type":0,"thumbnails":["https://s.yimg.com/uu/api/res/1.2/x096ECSowGg3Q1rFZ1g9Dg--~B/aD0zNDI7dz00ODA7YXBwaWQ9eXRhY2h5b24-/https://media.zenfs.com/en/business-wire.com/e0473bd79b4b38b19db2bf46f63a9a2e"],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://finance.yahoo.com/news/omeros-corporation-provides-progress-toward-141500569.html","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"0","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"yahoofinance","symbols":["LU2065732104.USD","PRGS","BK4097","OMER","BK4007"],"gpt_icon":0},{"id":"2484918600","title":"OMER S.p.a. Receives Buy Rating: Strong Financial Performance and Strategic Advancements Drive Confidence","url":"https://stock-news.laohu8.com/highlight/detail?id=2484918600","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484918600?lang=en_us&edition=fundamental","pubTime":"2024-11-19 17:35","pubTimestamp":1732008932,"startTime":"0","endTime":"0","summary":"In a report released today, Davide Longo from TP ICAP MIDCAP maintained a Buy rating on OMER S.p.a. (9WR – Research Report), with a price target of...","market":"us","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/blurbs/omer-s-p-a-receives-buy-rating-strong-financial-performance-and-strategic-advancements-drive-confidence?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":["rate"],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/blurbs/omer-s-p-a-receives-buy-rating-strong-financial-performance-and-strategic-advancements-drive-confidence?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER"],"gpt_icon":0},{"id":"2484228316","title":"OMER Reports Strong Third Quarter Growth","url":"https://stock-news.laohu8.com/highlight/detail?id=2484228316","media":"TIPRANKS","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2484228316?lang=en_us&edition=fundamental","pubTime":"2024-11-18 20:48","pubTimestamp":1731934121,"startTime":"0","endTime":"0","summary":"OMER S.p.a. (IT:OMER) has released an update. OMER S.p.A. has reported a robust double-digit growth in its main economic indicators for the third q...","market":"fut","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":{"source":"tipranks_highlight","url":"https://www.tipranks.com/news/company-announcements/omer-reports-strong-third-quarter-growth?utm_source=itigerup.com&utm_medium=referral","rn_cache_url":null,"directOrigin":true},"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://www.tipranks.com/news/company-announcements/omer-reports-strong-third-quarter-growth?utm_source=itigerup.com&utm_medium=referral","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":"tipranks_highlight","symbols":["OMER","BK4007"],"gpt_icon":0},{"id":"2483733857","title":"Omeros Shares Hit 52-Week High on Plan to Resubmit Narsoplimab Application","url":"https://stock-news.laohu8.com/highlight/detail?id=2483733857","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483733857?lang=en_us&edition=fundamental","pubTime":"2024-11-15 02:33","pubTimestamp":1731609180,"startTime":"0","endTime":"0","summary":"Shares of Omeros touched a 52-week high, a day after the company said it could resubmit its biologics license application for narsoplimab to the Food and Drug Administration.In Thursday afternoon trading, the stock had gained 47%, to $6.20. Earlier in the session, shares hit a high of $7.51.Omeros said it held a presubmission meeting with FDA for its biologics license application for narsoplimab in hematopoietic stem cell transplant-associated thrombotic microangiopathy. The National Institutes of Health said the disorder, also known as TA-TMA, can be triggered by several mechanisms during transplants.Following the meeting, the company said, it revised and resubmitted its statistical analysis plan, and now expects to receive a reply imminently. If the results support resubmission, the company said, it plans to finalize and resubmit the BLA as soon as possible.The biopharmaceutical company also said preparations are underway for a European marketing authorization application for narsopl","market":"hk","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["BK6045","OMER","PA3.SI","BK4007","BK6512"],"gpt_icon":0},{"id":"2483287678","title":"Omeros Initiated at Buy by Rodman & Renshaw","url":"https://stock-news.laohu8.com/highlight/detail?id=2483287678","media":"Dow Jones","labels":[],"top":-1,"itemType":null,"share":"https://ttm.financial/m/news/2483287678?lang=en_us&edition=fundamental","pubTime":"2024-11-14 20:04","pubTimestamp":1731585840,"startTime":"0","endTime":"0","summary":"Ratings actions from Benzinga: https://www.benzinga.com/quote/OMER/analyst-ratings \n\n\n \n\n\n  (END) Dow Jones Newswires\n\n\n  November 14, 2024 07:04 ET (12:04 GMT)","market":"sh","thumbnail":null,"type":0,"news_type":0,"thumbnails":[],"rights":null,"property":[],"language":"en","translate_title":"","themeId":null,"theme_name":"","theme_type":"","isJumpTheme":false,"source_url":"https://dowjonesnews.com/newdjn/logon.aspx?AL=N","is_publish_highlight":false,"source_rank":0,"column":"","sentiment":"1","news_top_title":null,"news_tag":"","news_rank":0,"length":0,"strategy_id":0,"source":null,"symbols":["OMER","BK4007"],"gpt_icon":0}],"pageSize":20,"totalPage":5,"pageCount":4,"totalSize":89,"code":"91000000","status":"200"}],"@#url:\"https://hq.skytigris.cn/fundamental/corporate_actions/details/OMER\",params:#limit:5,,,undefined,":[{"market":"US","date":"2025-03-31","symbol":"OMER","fiscalQuarterEnding":"2024/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1743393600000,"reportTimeType":"post","actualEps":-0.63},{"market":"US","date":"2024-11-13","symbol":"OMER","fiscalQuarterEnding":"2024/09","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1731474000000,"reportTimeType":"post","actualEps":-0.64},{"market":"US","date":"2024-08-07","symbol":"OMER","fiscalQuarterEnding":"2024/06","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1723003200000,"reportTimeType":"post","actualEps":-1.12},{"market":"US","date":"2024-05-15","symbol":"OMER","fiscalQuarterEnding":"2024/03","expectedEps":-0.61,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1715745600000,"reportTimeType":"post","actualEps":-0.74},{"market":"US","date":"2024-04-01","symbol":"OMER","fiscalQuarterEnding":"2023/12","expectedEps":null,"name":null,"time":"Post Market","type":"earning","dateTimestamp":1711944000000,"reportTimeType":"post","actualEps":-0.63}],"@#url:\"https://hq.skytigris.cn/fundamental/dividend/history\",params:#symbol:\"OMER\",market:\"US\",,,undefined,":[],"@#url:\"https://hq.skytigris.cn/fundamental/estimate/recommendation\",params:#symbol:\"OMER\",market:\"US\",delay:false,,,undefined,":{"strongBuy":0.25,"buy":0.25,"hold":0.5,"sell":0,"strongSell":0,"meanLabel":"BUY","meanPercent":0.25,"analysts":4,"updateTime":1735012800000},"@#url:\"https://hq.skytigris.cn/value_analysis/stock/OMER\",params:#withQuantilePoint:true,period:\"5year\",factor:\"peRate\",delay:false,algorithm:1,,,undefined,":{"brief":{"id":"OMER","date":"2025-05-06","current":-2.521539,"percent":0.480884,"low":-11.157955,"twenty":-6.720669,"median":-1.932332,"eighty":1.889016,"high":15.37984,"avg":-1.489488,"sd":5.602995,"marketCap":395415165},"quantilePoints":[{"date":"2020-05-08","current":-10.326483,"twenty":-13.24719,"median":-9.038964,"eighty":-6.26103,"marketCap":872443225},{"date":"2020-05-15","current":-8.613189,"twenty":-13.103323,"median":-9.035909,"eighty":-6.26103,"marketCap":768055298},{"date":"2020-05-22","current":-9.383425,"twenty":-13.053345,"median":-9.030721,"eighty":-6.26103,"marketCap":836738738},{"date":"2020-05-29","current":-9.096115,"twenty":-13.021459,"median":-9.030721,"eighty":-6.26103,"marketCap":811118724},{"date":"2020-06-05","current":-8.961629,"twenty":-12.956835,"median":-9.025886,"eighty":-6.26103,"marketCap":799126378},{"date":"2020-06-12","current":-8.946347,"twenty":-12.894904,"median":-9.020244,"eighty":-6.26103,"marketCap":797763611},{"date":"2020-06-19","current":-9.413989,"twenty":-12.852835,"median":-9.020244,"eighty":-6.26103,"marketCap":839464271},{"date":"2020-06-26","current":-8.973855,"twenty":-12.796751,"median":-9.01451,"eighty":-6.26103,"marketCap":800216591},{"date":"2020-07-02","current":-9.261165,"twenty":-12.655119,"median":-9.009611,"eighty":-6.26103,"marketCap":825836605},{"date":"2020-07-10","current":-8.319766,"twenty":-12.554938,"median":-8.996789,"eighty":-6.26103,"marketCap":741890177},{"date":"2020-07-17","current":-8.833256,"twenty":-12.515163,"median":-8.976987,"eighty":-6.26103,"marketCap":787679138},{"date":"2020-07-24","current":-8.497042,"twenty":-12.42537,"median":-8.965725,"eighty":-6.26103,"marketCap":757698271},{"date":"2020-07-31","current":-7.842954,"twenty":-12.334836,"median":-8.959084,"eighty":-6.26103,"marketCap":699371857},{"date":"2020-08-07","current":-8.637641,"twenty":-12.241023,"median":-8.946602,"eighty":-6.26103,"marketCap":770235724},{"date":"2020-08-14","current":-7.707331,"twenty":-12.229467,"median":-8.930834,"eighty":-6.26103,"marketCap":832491955},{"date":"2020-08-21","current":-7.076189,"twenty":-12.199873,"median":-8.908485,"eighty":-6.26103,"marketCap":764320352},{"date":"2020-08-28","current":-6.851593,"twenty":-12.145223,"median":-8.87718,"eighty":-6.26103,"marketCap":740061088},{"date":"2020-09-04","current":-5.685969,"twenty":-12.145223,"median":-8.848539,"eighty":-6.249005,"marketCap":614158580},{"date":"2020-09-11","current":-6.60141,"twenty":-12.145223,"median":-8.837076,"eighty":-6.247135,"marketCap":713038111},{"date":"2020-09-18","current":-6.999428,"twenty":-12.145223,"median":-8.823766,"eighty":-6.247135,"marketCap":756029211},{"date":"2020-09-25","current":-5.748515,"twenty":-12.145223,"median":-8.800149,"eighty":-6.234456,"marketCap":620914324},{"date":"2020-10-02","current":-5.936152,"twenty":-12.145223,"median":-8.797728,"eighty":-6.204224,"marketCap":641181557},{"date":"2020-10-09","current":-6.300054,"twenty":-12.145223,"median":-8.774048,"eighty":-6.200828,"marketCap":680487706},{"date":"2020-10-16","current":-6.550236,"twenty":-12.145223,"median":-8.752219,"eighty":-6.197499,"marketCap":707510684},{"date":"2020-10-23","current":-6.061243,"twenty":-12.145223,"median":-8.742733,"eighty":-6.196511,"marketCap":654693046},{"date":"2020-10-30","current":-5.765573,"twenty":-12.145223,"median":-8.722921,"eighty":-6.179043,"marketCap":622756800},{"date":"2020-11-06","current":-5.936152,"twenty":-12.145223,"median":-8.68675,"eighty":-6.171545,"marketCap":641181557},{"date":"2020-11-13","current":-5.510218,"twenty":-12.145223,"median":-8.652789,"eighty":-6.161094,"marketCap":716400028},{"date":"2020-11-20","current":-5.424862,"twenty":-12.145223,"median":-8.632051,"eighty":-6.141505,"marketCap":705302609},{"date":"2020-11-27","current":-5.567123,"twenty":-12.145223,"median":-8.618634,"eighty":-6.134342,"marketCap":723798307},{"date":"2020-12-04","current":-6.681495,"twenty":-12.145223,"median":-8.566282,"eighty":-6.117871,"marketCap":868681273},{"date":"2020-12-11","current":-6.890144,"twenty":-12.145223,"median":-8.520889,"eighty":-6.117871,"marketCap":895808296},{"date":"2020-12-18","current":-7.127245,"twenty":-12.145223,"median":-8.49598,"eighty":-6.117871,"marketCap":926634459},{"date":"2020-12-24","current":-7.065598,"twenty":-12.145223,"median":-8.482534,"eighty":-6.117871,"marketCap":918619657},{"date":"2020-12-31","current":-6.773965,"twenty":-12.145223,"median":-8.444543,"eighty":-6.117871,"marketCap":880703476},{"date":"2021-01-08","current":-7.591962,"twenty":-12.145223,"median":-8.402807,"eighty":-6.117871,"marketCap":987053739},{"date":"2021-01-15","current":-8.564074,"twenty":-12.145223,"median":-8.416099,"eighty":-6.117871,"marketCap":1113441007},{"date":"2021-01-22","current":-9.327538,"twenty":-12.145223,"median":-8.460826,"eighty":-6.117871,"marketCap":1212701252},{"date":"2021-01-29","current":-9.227956,"twenty":-12.145223,"median":-8.492924,"eighty":-6.117871,"marketCap":1199754263},{"date":"2021-02-05","current":-10.022243,"twenty":-12.145223,"median":-8.516863,"eighty":-6.117871,"marketCap":1303021910},{"date":"2021-02-12","current":-10.475105,"twenty":-12.145223,"median":-8.540758,"eighty":-6.117871,"marketCap":1361899881},{"date":"2021-02-19","current":-11.157955,"twenty":-12.145223,"median":-8.569767,"eighty":-6.117871,"marketCap":1450679230},{"date":"2021-02-26","current":-9.455573,"twenty":-12.145223,"median":-8.625152,"eighty":-6.117871,"marketCap":1229347380},{"date":"2021-03-05","current":-8.29008,"twenty":-12.147506,"median":-8.632168,"eighty":-6.11764,"marketCap":1144536734},{"date":"2021-03-12","current":-8.918116,"twenty":-12.147506,"median":-8.626225,"eighty":-6.11764,"marketCap":1231244063},{"date":"2021-03-19","current":-8.931574,"twenty":-12.147506,"median":-8.624079,"eighty":-6.11764,"marketCap":1233102077},{"date":"2021-03-26","current":-8.639986,"twenty":-12.145223,"median":-8.625152,"eighty":-6.117871,"marketCap":1192845103},{"date":"2021-04-01","current":-8.159987,"twenty":-12.145223,"median":-8.57449,"eighty":-6.117871,"marketCap":1126575931},{"date":"2021-04-09","current":-8.177931,"twenty":-12.147506,"median":-8.546634,"eighty":-6.11764,"marketCap":1129053283},{"date":"2021-04-16","current":-8.240734,"twenty":-12.147506,"median":-8.520284,"eighty":-6.11764,"marketCap":1137724016},{"date":"2021-04-23","current":-8.366342,"twenty":-12.147506,"median":-8.496435,"eighty":-6.11764,"marketCap":1155065481},{"date":"2021-04-30","current":-7.972285,"twenty":-12.147506,"median":-8.480252,"eighty":-6.11764,"marketCap":1100661707},{"date":"2021-05-07","current":-8.012914,"twenty":-12.147506,"median":-8.42883,"eighty":-6.11764,"marketCap":1106270968},{"date":"2021-05-14","current":-7.871054,"twenty":-12.147506,"median":-8.403369,"eighty":-6.136119,"marketCap":1134376334},{"date":"2021-05-21","current":-6.43956,"twenty":-12.147506,"median":-8.403369,"eighty":-6.148071,"marketCap":928069429},{"date":"2021-05-28","current":-6.569303,"twenty":-12.147506,"median":-8.403369,"eighty":-6.16359,"marketCap":946767940},{"date":"2021-06-04","current":-6.859062,"twenty":-12.147506,"median":-8.403369,"eighty":-6.172667,"marketCap":988527948},{"date":"2021-06-11","current":-6.837438,"twenty":-12.147506,"median":-8.403369,"eighty":-6.182806,"marketCap":985411529},{"date":"2021-06-18","current":-6.513081,"twenty":-12.147506,"median":-8.403369,"eighty":-6.197292,"marketCap":938665252},{"date":"2021-06-25","current":-6.750943,"twenty":-12.147506,"median":-8.403369,"eighty":-6.20883,"marketCap":972945855},{"date":"2021-07-02","current":-6.482808,"twenty":-12.147506,"median":-8.403369,"eighty":-6.24064,"marketCap":934302266},{"date":"2021-07-09","current":-6.318467,"twenty":-12.147506,"median":-8.403369,"eighty":-6.248365,"marketCap":910617485},{"date":"2021-07-16","current":-5.881667,"twenty":-12.147506,"median":-8.403369,"eighty":-6.248365,"marketCap":847665832},{"date":"2021-07-23","current":-6.136827,"twenty":-12.147506,"median":-8.403369,"eighty":-6.248365,"marketCap":884439570},{"date":"2021-07-30","current":-6.270895,"twenty":-12.147506,"median":-8.403369,"eighty":-6.25179,"marketCap":903761365},{"date":"2021-08-06","current":-6.353065,"twenty":-12.147506,"median":-8.403369,"eighty":-6.260545,"marketCap":915603755},{"date":"2021-08-13","current":-6.871791,"twenty":-12.147506,"median":-8.403369,"eighty":-6.264837,"marketCap":958058237},{"date":"2021-08-20","current":-6.620767,"twenty":-12.147506,"median":-8.403369,"eighty":-6.262849,"marketCap":923060676},{"date":"2021-08-27","current":-7.069024,"twenty":-12.147506,"median":-8.403369,"eighty":-6.269634,"marketCap":985556321},{"date":"2021-09-03","current":-7.060059,"twenty":-12.147506,"median":-8.403369,"eighty":-6.271323,"marketCap":984306408},{"date":"2021-09-10","current":-7.006268,"twenty":-12.147506,"median":-8.403369,"eighty":-6.271323,"marketCap":976806931},{"date":"2021-09-17","current":-7.163159,"twenty":-12.147506,"median":-8.403369,"eighty":-6.273665,"marketCap":998680407},{"date":"2021-09-24","current":-7.118333,"twenty":-12.147506,"median":-8.403369,"eighty":-6.273665,"marketCap":992430842},{"date":"2021-10-01","current":-3.828121,"twenty":-12.147506,"median":-8.403369,"eighty":-6.266873,"marketCap":533712808},{"date":"2021-10-08","current":-3.003327,"twenty":-12.147506,"median":-8.403369,"eighty":-6.266873,"marketCap":418720821},{"date":"2021-10-15","current":-3.465032,"twenty":-12.147506,"median":-8.403369,"eighty":-6.266873,"marketCap":483091335},{"date":"2021-10-22","current":-2.909193,"twenty":-12.147506,"median":-8.403369,"eighty":-6.266873,"marketCap":405596736},{"date":"2021-10-29","current":-2.810576,"twenty":-12.147506,"median":-8.403369,"eighty":-6.266873,"marketCap":391847694},{"date":"2021-11-05","current":-3.384346,"twenty":-12.147506,"median":-8.403369,"eighty":-6.266873,"marketCap":471842119},{"date":"2021-11-12","current":-4.152322,"twenty":-12.147506,"median":-8.403369,"eighty":-6.262849,"marketCap":513472020},{"date":"2021-11-19","current":-3.98542,"twenty":-12.147506,"median":-8.403369,"eighty":-6.24745,"marketCap":492833071},{"date":"2021-11-26","current":-3.757826,"twenty":-12.147506,"median":-8.403369,"eighty":-6.232102,"marketCap":464689051},{"date":"2021-12-03","current":-3.474599,"twenty":-12.147506,"median":-8.403369,"eighty":-6.212435,"marketCap":429665381},{"date":"2021-12-10","current":-3.828633,"twenty":-12.147506,"median":-8.403369,"eighty":-6.208979,"marketCap":473444968},{"date":"2021-12-17","current":-3.70725,"twenty":-12.147506,"median":-8.403369,"eighty":-6.208979,"marketCap":458434824},{"date":"2021-12-23","current":-3.864037,"twenty":-12.147506,"median":-8.403369,"eighty":-6.208979,"marketCap":477822927},{"date":"2021-12-31","current":-3.252062,"twenty":-12.147506,"median":-8.403369,"eighty":-6.208979,"marketCap":402146783},{"date":"2022-01-07","current":-3.17114,"twenty":-12.145223,"median":-8.403088,"eighty":-6.20883,"marketCap":392140020},{"date":"2022-01-14","current":-2.918258,"twenty":-12.145223,"median":-8.403088,"eighty":-6.20883,"marketCap":360868886},{"date":"2022-01-21","current":-2.680549,"twenty":-12.145223,"median":-8.403088,"eighty":-6.20883,"marketCap":331474020},{"date":"2022-01-28","current":-2.847451,"twenty":-12.145223,"median":-8.403088,"eighty":-6.20883,"marketCap":352112968},{"date":"2022-02-04","current":-3.176198,"twenty":-12.145223,"median":-8.403088,"eighty":-6.20883,"marketCap":392765443},{"date":"2022-02-11","current":-3.196428,"twenty":-12.145223,"median":-8.403088,"eighty":-6.20802,"marketCap":395267133},{"date":"2022-02-18","current":-3.585867,"twenty":-12.145223,"median":-8.403088,"eighty":-6.197499,"marketCap":443424680},{"date":"2022-02-25","current":-3.636443,"twenty":-12.145223,"median":-8.403088,"eighty":-6.183815,"marketCap":449678906},{"date":"2022-03-04","current":2.063595,"twenty":-12.145223,"median":-8.403088,"eighty":-6.17217,"marketCap":400822430},{"date":"2022-03-11","current":1.969942,"twenty":-12.145223,"median":-8.403088,"eighty":-6.162562,"marketCap":382631741},{"date":"2022-03-18","current":2.115266,"twenty":-12.145223,"median":-8.403088,"eighty":-6.140664,"marketCap":410858673},{"date":"2022-03-25","current":2.002236,"twenty":-12.145223,"median":-8.403088,"eighty":-6.120217,"marketCap":388904393},{"date":"2022-04-01","current":1.950566,"twenty":-12.145223,"median":-8.396774,"eighty":-6.056717,"marketCap":378868150},{"date":"2022-04-08","current":1.853683,"twenty":-12.145223,"median":-8.339069,"eighty":-6.018918,"marketCap":360050196},{"date":"2022-04-14","current":1.659919,"twenty":-12.145223,"median":-8.314163,"eighty":-6.002109,"marketCap":322414287},{"date":"2022-04-22","current":1.327289,"twenty":-12.145223,"median":-8.249706,"eighty":-5.965278,"marketCap":257805976},{"date":"2022-04-29","current":1.120607,"twenty":-12.145223,"median":-8.189075,"eighty":-5.945478,"marketCap":217661007},{"date":"2022-05-06","current":0.95273,"twenty":-12.145223,"median":-8.154657,"eighty":-5.920804,"marketCap":185053544},{"date":"2022-05-13","current":1.022525,"twenty":-12.145223,"median":-8.121882,"eighty":-5.881192,"marketCap":200736048},{"date":"2022-05-20","current":0.897905,"twenty":-12.145223,"median":-8.083623,"eighty":-5.862753,"marketCap":176271342},{"date":"2022-05-27","current":0.869147,"twenty":-12.145223,"median":-8.02734,"eighty":-5.807555,"marketCap":170625640},{"date":"2022-06-03","current":0.798848,"twenty":-12.145223,"median":-7.993462,"eighty":-5.745519,"marketCap":156825037},{"date":"2022-06-10","current":0.667837,"twenty":-12.145223,"median":-7.968807,"eighty":-5.711356,"marketCap":131105731},{"date":"2022-06-17","current":0.639078,"twenty":-12.069865,"median":-7.927209,"eighty":-5.69417,"marketCap":125460030},{"date":"2022-06-24","current":0.833997,"twenty":-11.921706,"median":-7.87737,"eighty":-5.660193,"marketCap":163725339},{"date":"2022-07-01","current":1.482662,"twenty":-11.868715,"median":-7.847865,"eighty":-5.590223,"marketCap":291067269},{"date":"2022-07-08","current":1.30372,"twenty":-11.868715,"median":-7.833786,"eighty":-5.573053,"marketCap":255938461},{"date":"2022-07-15","current":1.294134,"twenty":-11.804016,"median":-7.818817,"eighty":-5.520913,"marketCap":254056560},{"date":"2022-07-22","current":1.255789,"twenty":-11.577381,"median":-7.755586,"eighty":-5.495718,"marketCap":246528958},{"date":"2022-07-29","current":1.591305,"twenty":-11.237489,"median":-7.722395,"eighty":-5.441858,"marketCap":312395474},{"date":"2022-08-05","current":2.182453,"twenty":-10.860593,"median":-7.696194,"eighty":-5.402295,"marketCap":428446002},{"date":"2022-08-12","current":2.304801,"twenty":-10.730041,"median":-7.688088,"eighty":-5.339819,"marketCap":447265006},{"date":"2022-08-19","current":1.897501,"twenty":-10.595717,"median":-7.638236,"eighty":-5.271895,"marketCap":368225188},{"date":"2022-08-26","current":1.23483,"twenty":-10.520291,"median":-7.594754,"eighty":-5.228543,"marketCap":239628657},{"date":"2022-09-02","current":1.457875,"twenty":-10.468034,"median":-7.554347,"eighty":-5.170418,"marketCap":282912367},{"date":"2022-09-09","current":1.729409,"twenty":-10.421995,"median":-7.517872,"eighty":-5.022294,"marketCap":335605580},{"date":"2022-09-16","current":1.134621,"twenty":-10.305014,"median":-7.489604,"eighty":-4.920818,"marketCap":220182352},{"date":"2022-09-23","current":1.131389,"twenty":-10.25731,"median":-7.424659,"eighty":-4.748143,"marketCap":219555052},{"date":"2022-09-30","current":1.01825,"twenty":-10.198733,"median":-7.359011,"eighty":-4.308969,"marketCap":197599547},{"date":"2022-10-07","current":1.267155,"twenty":-10.048918,"median":-7.327188,"eighty":-4.094665,"marketCap":245901658},{"date":"2022-10-14","current":1.102296,"twenty":-9.986065,"median":-7.288557,"eighty":-3.936867,"marketCap":213909351},{"date":"2022-10-21","current":1.002087,"twenty":-9.889954,"median":-7.261456,"eighty":-3.837737,"marketCap":194463046},{"date":"2022-10-28","current":1.118459,"twenty":-9.852951,"median":-7.237109,"eighty":-3.747711,"marketCap":217045851},{"date":"2022-11-04","current":1.037645,"twenty":-9.81748,"median":-7.198375,"eighty":-3.688031,"marketCap":201363348},{"date":"2022-11-11","current":0.862398,"twenty":-9.741259,"median":-7.164791,"eighty":-3.618235,"marketCap":171880241},{"date":"2022-11-18","current":0.812039,"twenty":-9.649543,"median":-7.149711,"eighty":-3.541359,"marketCap":161843438},{"date":"2022-11-25","current":0.679847,"twenty":-9.602298,"median":-7.127245,"eighty":-3.487748,"marketCap":135496832},{"date":"2022-12-02","current":0.645225,"twenty":-9.524865,"median":-7.114468,"eighty":-3.45538,"marketCap":128596530},{"date":"2022-12-09","current":0.648372,"twenty":-9.43681,"median":-7.070341,"eighty":-3.402083,"marketCap":129223830},{"date":"2022-12-16","current":0.563391,"twenty":-9.394196,"median":-7.033164,"eighty":-3.34221,"marketCap":112286726},{"date":"2022-12-23","current":0.799449,"twenty":-9.369342,"median":-7.006268,"eighty":-3.260838,"marketCap":159334238},{"date":"2022-12-30","current":0.711321,"twenty":-9.344071,"median":-6.990795,"eighty":-3.222973,"marketCap":141769833},{"date":"2023-01-06","current":0.890725,"twenty":-9.317369,"median":-6.976684,"eighty":-3.182267,"marketCap":177525942},{"date":"2023-01-13","current":0.912757,"twenty":-9.306255,"median":-6.945557,"eighty":-3.169117,"marketCap":181917043},{"date":"2023-01-20","current":0.812039,"twenty":-9.278216,"median":-6.928929,"eighty":-3.107345,"marketCap":161843438},{"date":"2023-01-27","current":0.849808,"twenty":-9.261165,"median":-6.890263,"eighty":-3.022081,"marketCap":169371040},{"date":"2023-02-03","current":0.972558,"twenty":-9.247302,"median":-6.877536,"eighty":-2.888573,"marketCap":193835746},{"date":"2023-02-10","current":1.589456,"twenty":-9.227956,"median":-6.859062,"eighty":-2.841666,"marketCap":316786575},{"date":"2023-02-17","current":1.410052,"twenty":-9.209392,"median":-6.851593,"eighty":-2.708872,"marketCap":281030467},{"date":"2023-02-24","current":1.192879,"twenty":-9.206346,"median":-6.840413,"eighty":-2.615811,"marketCap":237746756},{"date":"2023-03-03","current":1.211764,"twenty":-9.198812,"median":-6.800829,"eighty":0.569686,"marketCap":241510557},{"date":"2023-03-10","current":1.026065,"twenty":-9.186032,"median":-6.781078,"eighty":0.623193,"marketCap":204499848},{"date":"2023-03-17","current":4.690593,"twenty":-9.148132,"median":-6.747884,"eighty":0.645323,"marketCap":222413828},{"date":"2023-03-24","current":5.114601,"twenty":-9.120787,"median":-6.720669,"eighty":0.663712,"marketCap":242519032},{"date":"2023-03-31","current":6.161372,"twenty":-9.114453,"median":-6.700334,"eighty":0.68064,"marketCap":292153757},{"date":"2023-04-04","current":6.121621,"twenty":-9.081444,"median":-6.684797,"eighty":0.687086,"marketCap":290268894},{"date":"2023-04-14","current":8.360915,"twenty":-9.053084,"median":-6.671801,"eighty":0.697449,"marketCap":396449507},{"date":"2023-04-21","current":6.903386,"twenty":-9.042422,"median":-6.644986,"eighty":0.711321,"marketCap":327337865},{"date":"2023-04-28","current":7.724902,"twenty":-9.0373,"median":-6.626265,"eighty":0.745751,"marketCap":366291699},{"date":"2023-05-01","current":7.685152,"twenty":-9.03254,"median":-6.625525,"eighty":0.76306,"marketCap":364406837},{"date":"2023-05-11","current":8.148229,"twenty":-8.994303,"median":-6.584267,"eighty":0.779109,"marketCap":380742315},{"date":"2023-05-18","current":7.986878,"twenty":-8.973043,"median":-6.569303,"eighty":0.796302,"marketCap":373202864},{"date":"2023-05-25","current":8.336472,"twenty":-8.953635,"median":-6.556228,"eighty":0.803856,"marketCap":389538343},{"date":"2023-06-02","current":9.788632,"twenty":-8.946857,"median":-6.530671,"eighty":0.812039,"marketCap":457393409},{"date":"2023-06-06","current":9.76174,"twenty":-8.94613,"median":-6.516121,"eighty":0.833997,"marketCap":456136833},{"date":"2023-06-15","current":8.161675,"twenty":-8.924951,"median":-6.500107,"eighty":0.845181,"marketCap":381370603},{"date":"2023-06-23","current":7.677622,"twenty":-8.910434,"median":-6.47632,"eighty":0.849941,"marketCap":358752248},{"date":"2023-06-30","current":7.139785,"twenty":-8.864265,"median":-6.441723,"eighty":0.85988,"marketCap":333620742},{"date":"2023-07-07","current":6.62884,"twenty":-8.837126,"median":-6.404962,"eighty":0.869147,"marketCap":309745811},{"date":"2023-07-14","current":6.843975,"twenty":-8.820981,"median":-6.391988,"eighty":0.886319,"marketCap":319798413},{"date":"2023-07-21","current":7.207015,"twenty":-8.803553,"median":-6.358783,"eighty":0.891869,"marketCap":336762180},{"date":"2023-07-27","current":5.929652,"twenty":-8.78047,"median":-6.351227,"eighty":0.897551,"marketCap":277074853},{"date":"2023-08-03","current":5.31114,"twenty":-8.755749,"median":-6.335351,"eighty":0.900797,"marketCap":248173621},{"date":"2023-08-11","current":6.553658,"twenty":-8.734226,"median":-6.298626,"eighty":0.914016,"marketCap":263994460},{"date":"2023-08-18","current":5.461382,"twenty":-8.702868,"median":-6.271609,"eighty":0.938806,"marketCap":219995384},{"date":"2023-08-25","current":5.49259,"twenty":-8.659134,"median":-6.261516,"eighty":0.978485,"marketCap":221252500},{"date":"2023-09-01","current":5.398966,"twenty":-8.641493,"median":-6.245305,"eighty":0.999601,"marketCap":217481151},{"date":"2023-09-08","current":5.29754,"twenty":-8.617545,"median":-6.225041,"eighty":1.016981,"marketCap":213395522},{"date":"2023-09-15","current":4.977659,"twenty":-8.567868,"median":-6.20883,"eighty":1.031074,"marketCap":200510078},{"date":"2023-09-20","current":4.82162,"twenty":-8.53088,"median":-6.203394,"eighty":1.037645,"marketCap":194224496},{"date":"2023-09-28","current":4.447125,"twenty":-8.501312,"median":-6.187861,"eighty":1.05898,"marketCap":179139098},{"date":"2023-10-03","current":4.322294,"twenty":-8.496435,"median":-6.181474,"eighty":1.069971,"marketCap":174110632},{"date":"2023-10-13","current":3.737146,"twenty":-8.498109,"median":-6.171425,"eighty":1.077082,"marketCap":150539698},{"date":"2023-10-19","current":2.192355,"twenty":-8.494233,"median":-6.16359,"eighty":1.082901,"marketCap":88312432},{"date":"2023-10-27","current":1.693028,"twenty":-8.44404,"median":-6.144012,"eighty":1.090659,"marketCap":68198569},{"date":"2023-11-03","current":1.903682,"twenty":-8.395793,"median":-6.135881,"eighty":1.108995,"marketCap":76684105},{"date":"2023-11-10","current":3.962294,"twenty":-8.353068,"median":-6.089879,"eighty":1.129037,"marketCap":79198338},{"date":"2023-11-17","current":4.749194,"twenty":-8.353068,"median":-6.089879,"eighty":1.142232,"marketCap":94926891},{"date":"2023-11-24","current":5.787097,"twenty":-8.353068,"median":-6.089879,"eighty":1.176644,"marketCap":115672503},{"date":"2023-12-01","current":6.887904,"twenty":-8.353068,"median":-6.089879,"eighty":1.197294,"marketCap":137675425},{"date":"2023-12-08","current":8.130243,"twenty":-8.348643,"median":-6.084511,"eighty":1.216492,"marketCap":162507294},{"date":"2023-12-15","current":9.026614,"twenty":-8.348643,"median":-6.084511,"eighty":1.229012,"marketCap":180423959},{"date":"2023-12-22","current":10.001614,"twenty":-8.348643,"median":-6.084511,"eighty":1.246842,"marketCap":199912261},{"date":"2023-12-29","current":11.070969,"twenty":-8.353068,"median":-6.089879,"eighty":1.258617,"marketCap":221286528},{"date":"2024-01-05","current":9.52984,"twenty":-8.357492,"median":-6.103412,"eighty":1.269661,"marketCap":190482437},{"date":"2024-01-12","current":11.605646,"twenty":-8.357492,"median":-6.103412,"eighty":1.290972,"marketCap":231973661},{"date":"2024-01-19","current":12.171776,"twenty":-8.361917,"median":-6.116945,"eighty":1.303519,"marketCap":243289450},{"date":"2024-01-26","current":10.536291,"twenty":-8.357492,"median":-6.103412,"eighty":1.327289,"marketCap":210599394},{"date":"2024-02-02","current":10.69355,"twenty":-8.357492,"median":-6.103412,"eighty":1.404967,"marketCap":213742669},{"date":"2024-02-09","current":10.410485,"twenty":-8.357492,"median":-6.103412,"eighty":1.436848,"marketCap":208084775},{"date":"2024-02-16","current":15.37984,"twenty":-8.357492,"median":-6.103412,"eighty":1.501822,"marketCap":307412250},{"date":"2024-02-23","current":13.068147,"twenty":-8.357492,"median":-6.103412,"eighty":1.520689,"marketCap":261206115},{"date":"2024-03-01","current":14.153227,"twenty":-8.353068,"median":-6.089879,"eighty":1.600637,"marketCap":282894709},{"date":"2024-03-08","current":14.216131,"twenty":-8.353068,"median":-6.038499,"eighty":1.664441,"marketCap":284152019},{"date":"2024-03-15","current":11.574195,"twenty":-8.353068,"median":-6.004383,"eighty":1.723236,"marketCap":231345006},{"date":"2024-03-22","current":11.542743,"twenty":-8.353068,"median":-5.965452,"eighty":1.760399,"marketCap":230716351},{"date":"2024-03-28","current":10.756453,"twenty":-8.353068,"median":-5.947524,"eighty":1.793616,"marketCap":214999979},{"date":"2024-04-05","current":-1.534476,"twenty":-8.357492,"median":-5.895544,"eighty":1.820673,"marketCap":180781208},{"date":"2024-04-12","current":-1.937768,"twenty":-8.357492,"median":-5.816746,"eighty":1.820673,"marketCap":228294218},{"date":"2024-04-19","current":-1.57874,"twenty":-8.357492,"median":-5.71582,"eighty":1.820673,"marketCap":185996050},{"date":"2024-04-26","current":-1.504967,"twenty":-8.353068,"median":-5.590833,"eighty":1.815529,"marketCap":177304646},{"date":"2024-05-03","current":-1.829614,"twenty":-8.353068,"median":-5.500734,"eighty":1.815529,"marketCap":215552271},{"date":"2024-05-10","current":-1.750921,"twenty":-8.353068,"median":-5.424862,"eighty":1.815529,"marketCap":206281206},{"date":"2024-05-17","current":-1.581216,"twenty":-8.353068,"median":-4.192783,"eighty":1.815529,"marketCap":191795166},{"date":"2024-05-24","current":-1.571662,"twenty":-8.353068,"median":-4.061285,"eighty":1.815529,"marketCap":190636283},{"date":"2024-05-31","current":-1.585993,"twenty":-8.353068,"median":-3.944959,"eighty":1.815529,"marketCap":192374607},{"date":"2024-06-07","current":-1.867841,"twenty":-8.353068,"median":-3.843806,"eighty":1.815529,"marketCap":226561661},{"date":"2024-06-14","current":-2.020708,"twenty":-8.357492,"median":-3.775528,"eighty":1.820673,"marketCap":245103792},{"date":"2024-06-21","current":-1.889338,"twenty":-8.361917,"median":-3.702192,"eighty":1.825816,"marketCap":229169148},{"date":"2024-06-28","current":-1.88695,"twenty":-8.372164,"median":-3.654145,"eighty":1.840049,"marketCap":228879428},{"date":"2024-07-05","current":-1.85351,"twenty":-8.372164,"median":-3.588395,"eighty":1.840049,"marketCap":224823336},{"date":"2024-07-12","current":-2.030262,"twenty":-8.372164,"median":-3.527703,"eighty":1.840049,"marketCap":246262675},{"date":"2024-07-15","current":-2.039816,"twenty":-8.372164,"median":-3.507473,"eighty":1.840049,"marketCap":247421558},{"date":"2024-08-02","current":-2.398098,"twenty":-8.403369,"median":-3.44931,"eighty":1.876289,"marketCap":290879678},{"date":"2024-08-09","current":-1.617876,"twenty":-8.403369,"median":-3.384346,"eighty":1.876289,"marketCap":226572218},{"date":"2024-08-16","current":-1.756492,"twenty":-8.33392,"median":-3.33952,"eighty":1.876289,"marketCap":245984416},{"date":"2024-08-23","current":-1.70477,"twenty":-8.302955,"median":-3.25712,"eighty":1.876289,"marketCap":238741059},{"date":"2024-08-30","current":-1.684081,"twenty":-8.209332,"median":-3.196428,"eighty":1.876289,"marketCap":235843716},{"date":"2024-09-06","current":-1.638565,"twenty":-8.18292,"median":-3.176198,"eighty":1.876289,"marketCap":229469561},{"date":"2024-09-13","current":-1.547534,"twenty":-8.142043,"median":-3.155967,"eighty":1.876289,"marketCap":216721252},{"date":"2024-09-20","current":-1.66753,"twenty":-8.094615,"median":-3.08516,"eighty":1.876289,"marketCap":233525841},{"date":"2024-09-27","current":-1.622014,"twenty":-8.038865,"median":-2.918258,"eighty":1.876289,"marketCap":227151687},{"date":"2024-10-04","current":-1.568223,"twenty":-8.038865,"median":-2.859884,"eighty":1.876289,"marketCap":219618595},{"date":"2024-10-11","current":-1.576498,"twenty":-8.038865,"median":-2.788163,"eighty":1.876289,"marketCap":220777532},{"date":"2024-10-18","current":-1.713045,"twenty":-8.038865,"median":-2.680549,"eighty":1.876289,"marketCap":239899996},{"date":"2024-10-25","current":-1.754423,"twenty":-8.038865,"median":-2.398098,"eighty":1.876289,"marketCap":245694682},{"date":"2024-10-31","current":-1.746148,"twenty":-8.034379,"median":-2.065693,"eighty":1.876289,"marketCap":244535744},{"date":"2024-11-08","current":-1.862006,"twenty":-8.0346,"median":-1.946663,"eighty":1.880531,"marketCap":260760865},{"date":"2024-11-15","current":-2.993873,"twenty":-8.012143,"median":-1.936244,"eighty":1.880531,"marketCap":402750832},{"date":"2024-11-22","current":-3.329877,"twenty":-7.970876,"median":-1.936244,"eighty":1.880531,"marketCap":447951644},{"date":"2024-11-29","current":-4.889275,"twenty":-7.930753,"median":-1.936244,"eighty":1.880531,"marketCap":657729776},{"date":"2024-12-06","current":-4.781582,"twenty":-7.856637,"median":-1.936244,"eighty":1.880531,"marketCap":643242336},{"date":"2024-12-13","current":-3.657264,"twenty":-7.833786,"median":-1.936244,"eighty":1.880531,"marketCap":491993462},{"date":"2024-12-20","current":-4.411117,"twenty":-7.709802,"median":-1.936244,"eighty":1.880531,"marketCap":593405542},{"date":"2024-12-27","current":-4.505887,"twenty":-7.654468,"median":-1.936244,"eighty":1.880531,"marketCap":606154489},{"date":"2025-01-03","current":-4.238808,"twenty":-7.59252,"median":-1.936244,"eighty":1.880531,"marketCap":570225638},{"date":"2025-01-10","current":-4.260347,"twenty":-7.360739,"median":-1.93472,"eighty":1.884774,"marketCap":573123126},{"date":"2025-01-17","current":-3.954498,"twenty":-7.24211,"median":-1.93472,"eighty":1.884774,"marketCap":531978796},{"date":"2025-01-24","current":-3.881266,"twenty":-7.193465,"median":-1.93472,"eighty":1.884774,"marketCap":522127337},{"date":"2025-01-31","current":-3.808035,"twenty":-7.152105,"median":-1.93472,"eighty":1.884774,"marketCap":512275878},{"date":"2025-02-07","current":-3.91142,"twenty":-7.119649,"median":-1.93472,"eighty":1.884774,"marketCap":526183820},{"date":"2025-02-14","current":-3.928651,"twenty":-7.07268,"median":-1.93472,"eighty":1.884774,"marketCap":528501811},{"date":"2025-02-21","current":-4.13973,"twenty":-7.061852,"median":-1.93472,"eighty":1.884774,"marketCap":556897193},{"date":"2025-02-28","current":-3.670187,"twenty":-7.011032,"median":-1.93472,"eighty":1.884774,"marketCap":493731955},{"date":"2025-03-07","current":-3.220029,"twenty":-6.978297,"median":-1.932332,"eighty":1.889016,"marketCap":433174456},{"date":"2025-03-14","current":-3.385877,"twenty":-6.949297,"median":-1.932332,"eighty":1.889016,"marketCap":455485113},{"date":"2025-03-21","current":-3.920036,"twenty":-6.94087,"median":-1.932332,"eighty":1.889016,"marketCap":527342816},{"date":"2025-03-28","current":-3.842497,"twenty":-6.888247,"median":-1.932332,"eighty":1.889016,"marketCap":516911859},{"date":"2025-04-04","current":-2.725188,"twenty":-6.868205,"median":-1.932332,"eighty":1.889016,"marketCap":427350311},{"date":"2025-04-11","current":-2.169783,"twenty":-6.851593,"median":-1.93472,"eighty":1.884774,"marketCap":340254459},{"date":"2025-04-17","current":-2.503026,"twenty":-6.838628,"median":-1.93472,"eighty":1.884774,"marketCap":392511970},{"date":"2025-04-25","current":-2.702972,"twenty":-6.773405,"median":-1.932332,"eighty":1.889016,"marketCap":423866477},{"date":"2025-05-02","current":-2.599296,"twenty":-6.729864,"median":-1.932332,"eighty":1.889016,"marketCap":407608585},{"date":"2025-05-06","current":-2.521539,"twenty":-6.720669,"median":-1.932332,"eighty":1.889016,"marketCap":395415165}],"updateTime":1746624367963}}}